Results 121 to 130 of about 3,554 (229)

Effects of treatment for acromegaly on Bone Mineral Density (BMD): is Pegvisomant protective on lumbar BMD? [PDF]

, 2013
The abstract deals with the different effects of treatments for acromegaly on ...
BRIGANTE, Giulia, CARANI, Cesare, DIAZZI, Chiara, G. Ferrannini, MADEO, Bruno, ROCHIRA, Vincenzo, S. De Vincentis, SANTI, Daniele, SIMONI, Manuela   +8 more
core  

Pegvisomant home care programme leading to rapid IGF1 control likely improves quality of life [PDF]

, 2015
Els Rutten, Guy T’Sjoen, Bruno Lapauw, Charlotte Verroken, Els Feyen   +4 more
openalex   +1 more source

Are there country-specific differences in the use of pegvisomant for acromegaly in clinical practice? An analysis from ACROSTUDY [PDF]

, 2022
Silvia Grottoli, Antonio Bianchi, Fausto Bogazzi, Chiara Bona, Martin Carlsson, Annamaria Colao, Francesca Dassie, Antonella Giampietro, Roy Gomez, S. Granato, Pietro Maffei, Rosario Pivonello, Nunzia Prencipe, M. Ragonese, Claudio Urbani, Salvatore Cannavò   +15 more
openalex   +1 more source

Efficacy and safety of high-dose long-acting repeatable octreotide as monotherapy or in combination with pegvisomant or cabergoline in patients with acromegaly not adequately controlled by conventional regimens: results of an open-label, multicentre study

, 2019
Annamaria Colao, Wojciech Zgliczyński, Jan Komorowski, Beata Kos‐Kudła, Antoine Tabarin, V. Kerlan, Francesco Minuto, Carla Scaroni, Marek Bolanowski   +8 more
openalex   +2 more sources

Effectiveness of first-line pegvisomant monotherapy in acromegaly: an ACROSTUDY analysis [PDF]

, 2016
Nicholas A. Tritos, Philippe Chanson, Camilo Jiménez, Donna King, Peter Jönsson, Anne Klibanski, Beverly M. K. Biller   +6 more
openalex   +1 more source

The Impact of Pegvisomant Treatment on Substrate Metabolism and Insulin Sensitivity in Patients with Acromegaly [PDF]

, 2007
Rune Lindberg-Larsen, Niels Møller, Ole Schmitz, Søren Nielsen, Marianne Andersen, Hans Ørskov, Jens Otto Lunde Jørgensen   +6 more
openalex   +1 more source

Supplementary Material for: Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with Pegvisomant

, 2016
Sanne Franck, Federico Gatto, A. J. van der Lely, J. A. M. J. L. Janssen, A.H.G. Dallenga, A. Paul Nagtegaal, Leo J. Hofland, SJ Neggers   +7 more
openalex   +1 more source

Pegvisomant increases intra-abdominal fat in patients with acromegaly: a pilot study. [PDF]

, 2008
Ursula Plöckinger, T Reuter
openalex   +1 more source

Clinical applications of somatostatin analogs for growth hormone-secreting pituitary adenomas

Patient Preference and Adherence, 2014
Ji-wen Wang,1,2 Ying Li,3 Zhi-gang Mao,1,2 Bin Hu,1,2 Xiao-bing Jiang,1,2 Bing-bing Song,4 Xin Wang,4 Yong-hong Zhu,4 Hai-jun Wang1,21Department of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital, Sun Yat-sen University, 2Key ...
Wang JW, Li Y, Mao ZG, Hu B, Jiang XB, Song BB, Wang X, Zhu YH, Wang HJ   +8 more
doaj  

Van Docter Bernardo naar Endocriene Weesaandoeningen [PDF]

, 2011
Rede, uitgesproken ter gelegenheid van het aanvaarden van het ambt van bijzonder hoogleraar met als leeropdracht Endocriene oncologie aan het Erasmus MC, faculteit van de Erasmus Universiteit Rotterdam op 24 november ...
Herder, W.W. (Wouter) de
core